MTCO1P20

Across TCGA pan-cancer cohorts, MTCO1P20 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated MTCO1P20 data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher MTCO1P20 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTCO1P20 expression acts as an unfavorable survival marker, although some lineages such as CESC and UCS show a favorable association.

TGCT, READ, and UVM are the cancer types where MTCO1P20 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	OS	Tertile	III,IV	0.003	1.000	<.001	72	view →
READ	OS	Tertile	III,IV	0.214	0.798	<.001	57	view →
UVM	DFS	Tertile	All	0.149	0.766	.001	54	view →
CESC	OS	Tertile	II,III,IV	0.908	0.706	.023	48	view →
UCS	DFS	Tertile	All	0.760	0.445	.017	42	view →
LUAD	OS	Tertile	II,III,IV	0.397	0.619	.020	39	view →
ACC	OS	Tertile	All	0.133	0.686	.004	36	view →
STAD	OS	Tertile	III,IV	0.751	0.572	.019	28	view →
LGG	OS	Tertile	All	0.317	0.496	<.001	28	view →
PCPG	OS	Tertile	All	0.618	0.967	.001	27	view →
ESCA	DFS	Tertile	III,IV	0.518	0.256	.018	25	view →
DLBC	OS	Tertile	All	0.638	0.931	.006	24	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

MTCO1P20–TGCT (OS)

Open the TGCT breakdown →